What is Tissx?
Tissx operates at the intersection of medical device innovation and advanced biomaterials. The company specializes in the sourcing, manufacturing, and supply of sophisticated tissue-based products and services tailored for cardiac, vascular, and specialized surgical procedures. Their product portfolio includes essential items such as fixed tissue pericardial patches and heart valve repair components. Beyond their proprietary offerings, Tissx extends its expertise to provide Original Equipment Manufacturer (OEM) services, aiding clients in the development of tissue bio-prosthetics. Operating within an ISO-certified facility underscores their commitment to stringent quality standards. The company's strategic collaborations aim to expedite the market entry of novel medical device therapies, leveraging an experienced team dedicated to innovation.
How much funding has Tissx raised?
Tissx has raised a total of $36K across 1 funding round:
Debt
$36K
Debt (2021): $36K with participation from PPP
Key Investors in Tissx
PPP
Public-Private Partnership
What's next for Tissx?
With substantial expansion capital secured, Tissx is poised for a significant scaling phase. The company's focus on tissue-based surgical applications, coupled with its OEM capabilities, suggests a strategic direction towards broadening its product lines and enhancing manufacturing capacity. This funding will likely fuel advancements in research and development, potentially leading to new therapeutic solutions in cardiac and vascular surgery. Furthermore, Tissx may explore strategic partnerships or acquisitions to accelerate market penetration and solidify its position as a key player in the medical device sector. The company's commitment to quality and innovation, as evidenced by its ISO certification, provides a strong foundation for future growth and market leadership.
See full Tissx company page
